A recent report published by Infinium Global Research on needle-free diabetes care market provides an in-depth analysis of segments and sub-segments in the global as well as regional needle-free diabetes care market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional needle-free diabetes care market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global needle-free diabetes care market. According to the report, the global needle-free diabetes care market is projected to grow at a CAGR of 7.8% over the forecast period of 2019-2025.
Needle-free diabetes care refers to the measurement of blood glucose level with the help of biosensor and administration of insulin into the human body without the pricking or removal of the blood. Diabetes is a metabolic disorder in which an imbalance of blood glucose level occurs due to the inadequate production of insulin in the body. Low level of blood glucose can cause Symptoms like hyperglycaemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue, and impaired vision. A traditional way to test blood sugar level is usually by pricking their finger with a lancet. This is a painful and uncomfortable process which may lead to less frequent testing and results in improper control of blood sugar level. Needle-free devices like transdermal biosensor, subcutaneous implants, and devices with the combination of ultrasonic, electromagnetic and thermal waves provide an easy way to measure blood glucose level and help into proper administration of insulin in the human body.
A growing number of diabetic patients globally are boosting the demand for diabetic care products. Also, the prevalence of diabetes is rising more rapidly in middle and low-income countries are contributing to the rising demand for diabetic care products. Moreover painful traditional methods and discomfort associated with the detection of blood glucose level and administer insulin has become a major driver for the demand of needle-free diabetic care products. On the other hand, the high cost associated with the devices and technical illiteracy can restrain the needle-free diabetes care market. However, the production of cost-effective devices with extensive R and D and approval for newer products from regulatory bodies can provide a good opportunity to needle-free diabetes care market.
Geographically global needle-free diabetes care market categorized into North America, Europe, Asia Pacific and the Rest of the World. North America expected to dominate the region in terms of revenue share. A rise in research and development activities, increasing healthcare expenditure and increasing awareness regarding diabetes management are some factors boosting the growth of the market in this region. Asia-pacific anticipated growing with a high CAGR in the forecast period. A tremendous rise in diabetic patients and increasing adoption for advanced diabetic therapy will make the region dominant in the near future. Europe is another growing region and expected to grow with a consistent rate in the forecast period.
The report on global needle-free diabetes care market covers segments such as device type, and end-user. On the basis of device type, the sub-markets include insulin patches, jet injectors, insulin pens, insulin pumps, and insulin infuser. On the basis of end-user, the sub-markets include diagnostic centres, hospitals and clinics, and consumer.
The report provides profiles of the companies in the market such as Antares Pharma, Inc., European Pharma Group BV, Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies Inc., The 3M Company, Echo Therapeutics Inc., MannKind Corporation, Akra Dermojet, Medical International Technology, Inc., and Other companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of needle-free diabetes care market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter